News

Filter

Current filters:

Women's HealthLegal

Mylan settles over generic Generess tablets and launches insomnia drug

Mylan settles over generic Generess tablets and launches insomnia drug

16-04-2014

US generics major Mylan (Nasdaq: MYL) and its partner Famy Care have entered into a settlement and license…

ActavisFamy CareGeneress FeGenericsHealth Medical PharmaLegalLunestaMylanMylan LaboratoriesPharmaceutical sciencesPharmacologyUSAWomen's Health

US federal judge tells FDA to lift age restrictions on morning-after pill

05-04-2013

A US federal judge has ordered the Food and Drug Administration to lift age and other restrictions on…

LegalPharmaceuticalPlan BReproductiveTeva Pharmaceutical IndustriesWomen's Health

Watson settles with Janssen over Ortho Tri-Cyclen LO

08-02-2012

US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

COMPANY SPOTLIGHT

Menarini

Back to top